Clinical trial
Safety and Effectiveness of Early Aspirin Administration After Mitral Valve Repair: a Prospective, Non-inferiority, Randomized Controlled Clinical Trial Protocol
NCT06738992 is registered in ClinicalTrials.gov with Guangdong Provincial People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Effectiveness of Early Aspirin Administration After Mitral Valve Repair: a Prospective, Non-inferiority, Randomized Controlled Clinical Trial Protocol
- Lead sponsor
- Guangdong Provincial People's Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- November 14, 2024
- Completion date
- December 31, 2027
- Enrollment
- 384 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mitral valve repair surgery